Nanjing Zhongrui Pharmaceutical

Nanjing Sunray Pharmaceutical, also known as Nanjing Zhongrui Pharmaceutical, is a China-based pharmaceutical company specializing in the research, development, and manufacturing of chemical APIs and finished dosage forms. The company focuses primarily on cardiovascular, anti-infective, and metabolic therapeutic areas, producing a range of generic medications including ACE inhibitors and statins. With a strong emphasis on quality control and GMP-compliant manufacturing, Nanjing Sunray serves both domestic and international markets. The firm operates integrated facilities that cover the entire production chain from chemical synthesis to final packaging.